166 related articles for article (PubMed ID: 22700206)
1. ▼Asenapine for bipolar I disorder?
Drug Ther Bull; 2012 Jun; 50(6):69-72. PubMed ID: 22700206
[TBL] [Abstract][Full Text] [Related]
2. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2009 Dec; 63(12):1762-84. PubMed ID: 19840150
[TBL] [Abstract][Full Text] [Related]
3. Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice.
Fagiolini A; Forgione RN; Morana B; Maccari M; Goracci A; Bossini L; Pellegrini F; Cuomo A; Casamassima F
Expert Opin Pharmacother; 2013 Mar; 14(4):489-504. PubMed ID: 23356509
[TBL] [Abstract][Full Text] [Related]
4. Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder.
Szegedi A; Durgam S; Mackle M; Yu SY; Wu X; Mathews M; Landbloom RP
Am J Psychiatry; 2018 Jan; 175(1):71-79. PubMed ID: 28946761
[TBL] [Abstract][Full Text] [Related]
5. Asenapine: a new antipsychotic option.
Henry JM; Fuller MA
J Pharm Pract; 2011 Oct; 24(5):447-51. PubMed ID: 22156709
[TBL] [Abstract][Full Text] [Related]
6. Asenapine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I Disorder.
Findling RL; Landbloom RL; Szegedi A; Koppenhaver J; Braat S; Zhu Q; Mackle M; Chang K; Mathews M
J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):1032-41. PubMed ID: 26598478
[TBL] [Abstract][Full Text] [Related]
7. Asenapine: a less effective, yet, more dangerous neuroleptic!
Prescrire Int; 2012 Oct; 21(131):229-32. PubMed ID: 23185842
[TBL] [Abstract][Full Text] [Related]
8. Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
J Affect Disord; 2010 Apr; 122(1-2):27-38. PubMed ID: 20096936
[TBL] [Abstract][Full Text] [Related]
9. Asenapine for elderly bipolar manic patients.
Baruch Y; Tadger S; Plopski I; Barak Y
J Affect Disord; 2013 Feb; 145(1):130-2. PubMed ID: 22877962
[TBL] [Abstract][Full Text] [Related]
10. Asenapine.
Meltzer HY; Dritselis A; Yasothan U; Kirkpatrick P
Nat Rev Drug Discov; 2009 Nov; 8(11):843-4. PubMed ID: 19876039
[TBL] [Abstract][Full Text] [Related]
11. Use of asenapine as add-on therapy in the treatment of bipolar disorder: a comprehensive review and case series.
Dell'Osso B; Cremaschi L; Palazzo MC; Spagnolin G; Cattaneo A; Grancini B; Maggi M; Altamura AC
Expert Opin Drug Saf; 2014 Sep; 13(9):1199-208. PubMed ID: 25084462
[TBL] [Abstract][Full Text] [Related]
12. A Review of Asenapine in the Treatment of Bipolar Disorder.
Vieta E; Montes JM
Clin Drug Investig; 2018 Feb; 38(2):87-99. PubMed ID: 29067671
[TBL] [Abstract][Full Text] [Related]
13. Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.
Szegedi A; Calabrese JR; Stet L; Mackle M; Zhao J; Panagides J;
J Clin Psychopharmacol; 2012 Feb; 32(1):46-55. PubMed ID: 22198448
[TBL] [Abstract][Full Text] [Related]
14. Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder.
Landbloom RL; Mackle M; Wu X; Kelly L; Snow-Adami L; McIntyre RS; Mathews M; Hundt C
J Affect Disord; 2016 Jan; 190():103-110. PubMed ID: 26496015
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology and efficacy of asenapine for manic and mixed states in adults with bipolar disorder.
McIntyre RS
Expert Rev Neurother; 2010 May; 10(5):645-9. PubMed ID: 20420486
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety and tolerability of asenapine: A double-blind, uncontrolled, long-term extension trial in adults with an acute manic or mixed episode associated with bipolar I disorder.
Ketter TA; Durgam S; Landbloom R; Mackle M; Wu X; Mathews M
J Affect Disord; 2017 Jan; 207():384-392. PubMed ID: 27755982
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of asenapine for acute mania in bipolar I disorder: meta-analyses of randomized-controlled trials.
Vita A; De Peri L; Siracusano A; Sacchetti E;
Int Clin Psychopharmacol; 2013 Sep; 28(5):219-27. PubMed ID: 23719049
[TBL] [Abstract][Full Text] [Related]
18. Asenapine prescribing patterns in the treatment of manic in- and outpatients: Results from the MANACOR study.
Grande I; Hidalgo-Mazzei D; Nieto E; Mur M; Sàez C; Forcada I; Vieta E
Eur Psychiatry; 2015 Jun; 30(4):528-34. PubMed ID: 25682181
[TBL] [Abstract][Full Text] [Related]
19. Use of asenapine in clinical practice for the management of bipolar mania.
Young AH; Altamura AC; González-Pinto AM; Millet B; Wiedemann K
J Psychopharmacol; 2013 Apr; 27(4 Suppl):3-13. PubMed ID: 23535350
[TBL] [Abstract][Full Text] [Related]
20. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
